The Risk-based Monitoring Software Market is experiencing substantial growth, driven by the increasing complexity of clinical trials, regulatory requirements, and the adoption of technology-driven solutions in the life sciences industry. According to the latest market report, the market size was valued at USD 8.20 billion in 2022 and is projected to reach USD 14.96 billion by 2030, showcasing...